Literature DB >> 14599817

Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses.

Lakshmi Sastry1, Yi Xu, Terry Johnson, Kunal Desai, David Rissing, Jonathan Marsh, Kenneth Cornetta.   

Abstract

A principal concern regarding the safety of HIV-1-based vectors is replication-competent lentivirus (RCL). We have developed two PCR assays for detecting RCL; the first detects recombination between gag regions in the transfer vector and the packaging construct (sensitivity of detection approximately 10-100 copies of target sequence). The second assay uses real-time PCR to detect vesicular stomatitis virus glycoprotein (VSVG) envelope DNA (sensitivity approximately 5-50 VSVG sequences). In an attempt to amplify any RCL, test vectors were used to transduce C8166 and 293 cells, which were then screened weekly for 3 weeks. Psi-gag recombinants were routinely detected (20 of 21 analyses) in four transductions using the RRL-CMV-GFP vector. In contrast, VSVG sequences were detected only once in 21 analyses. Interestingly, p24 levels (as measured by ELISA) were occasionally detectable after 3 weeks of culture. To determine if a true RCL was present, 21-day cell-free medium was used to transduce naïve cells. No evidence of psi-gag or VSVG transfer was detected, indicating that the recombination events were insufficient to reconstitute a true RCL. These findings have important implications for the design and safety of HIV-1-based vectors intended for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599817     DOI: 10.1016/j.ymthe.2003.08.003

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  26 in total

1.  Replication-competent lentivirus analysis of clinical grade vector products.

Authors:  Kenneth Cornetta; Jing Yao; Aparna Jasti; Sue Koop; Makhaila Douglas; David Hsu; Larry A Couture; Troy Hawkins; Lisa Duffy
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

2.  Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors.

Authors:  Hideki Hanawa; Derek A Persons; Arthur W Nienhuis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector.

Authors:  D Nicole Worsham; Todd Schuesler; Christof von Kalle; Dao Pan
Journal:  Mol Ther       Date:  2006-08-07       Impact factor: 11.454

4.  Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo.

Authors:  Yung-Wei Pan; Jarrad M Scarlett; Tammy T Luoh; Peter Kurre
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Analysis of partial recombinants in lentiviral vector preparations.

Authors:  Seraphin Kuate; Michael P Marino; Jakob Reiser
Journal:  Hum Gene Ther Methods       Date:  2014-02-14       Impact factor: 2.396

6.  Neurotrophic factor-secreting autologous muscle stem cell therapy for the treatment of laryngeal denervation injury.

Authors:  Stacey L Halum; Bryan McRae; Khadijeh Bijangi-Vishehsaraei; Kelly Hiatt
Journal:  Laryngoscope       Date:  2012-09-10       Impact factor: 3.325

7.  Enhanced genetic modification of adult growth factor mobilized peripheral blood hematopoietic stem and progenitor cells with rapamycin.

Authors:  Lijing Li; Mónica Torres-Coronado; Angel Gu; Anitha Rao; Agnes M Gardner; Elizabeth W Epps; Nancy Gonzalez; Chy-Anh Tran; Xiwei Wu; Jin-Hui Wang; David L DiGiusto
Journal:  Stem Cells Transl Med       Date:  2014-08-08       Impact factor: 6.940

8.  False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector.

Authors:  Suk See De Ravin; John T Gray; Robert E Throm; Jon Spindler; Mary Kearney; Xiaolin Wu; John M Coffin; Stephen H Hughes; Frank Malderelli; Brian P Sorrentino; Harry L Malech
Journal:  Mol Ther       Date:  2014-02       Impact factor: 11.454

9.  Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells.

Authors:  Semih U Tareen; Brenna Kelley-Clarke; Christopher J Nicolai; Linda A Cassiano; Lisa T Nelson; Megan M Slough; Chintan D Vin; Jared M Odegard; Derek D Sloan; Neal Van Hoeven; James M Allen; Thomas W Dubensky; Scott H Robbins
Journal:  Mol Ther       Date:  2013-12-06       Impact factor: 11.454

10.  Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.

Authors:  Kenneth Cornetta; Lisa Duffy; Cameron J Turtle; Michael Jensen; Stephen Forman; Gwendolyn Binder-Scholl; Terry Fry; Anne Chew; David G Maloney; Carl H June
Journal:  Mol Ther       Date:  2017-09-12       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.